(1)
Abooshahab, R.; Al-Salami, H.; Dass, C. R. Targeting Metabolic Vulnerabilities in Breast Cancer Cells by Combining PEDF and Doxorubicin: Pathway Insights from GC MS-Based Metabolomics. EXCLI J. 2025, 24, 1037-1055.